Psychedelics in the news

Psychedelics will create new modalities in medicine, society and public markets

FDA approved studies are yielding transformative results for psychedelics as medicine to treat a wide range of mental and physical health conditions. Within the last couple of years, the prospect of cures for treatment-resistant diseases, such as major depression, PTSD, and addiction, is racing toward reality with a handful of pioneering companies and world class universities leading the charge.

The movement is creating tremendous promise for people suffering with these debilitating diseases and a deep sense of accomplishment for those who have long sought to include psychedelics in scientific consideration as a viable treatment modality.

While psychedelics are expected to heal tens of millions globally and transcend the way we think about the mind and human consciousness, it is also creating unprecedented investment opportunities with the first IPOs happening earlier this year, and jurisdictions around the country are moving to decriminalize use and possession.

Our News section will keep readers informed with all of the latest industry updates with regard to research progress, investor news and cultural reform.

Shutterstock

TDR’s Top 5 Psychedelic Developments For The Week of June 29

Investor News

TDR’s Top 5 Psychedelic Developments For The Week of June 29

July 6, 2020
TDR Editorial Board
Psilocybin Technology

Champignon Brands Issued Cease Trade Order By B.C. Securities Commission

Investor News

Despite a strong rally in psychedelic stocks to close the week, industry leader Champignon Brands was a notable laggard.

July 6, 2020
TDR Editorial Team
Wikimedia Commons

From Hippies to Modern Psychotherapy, A Psychedelics Handbook for the Willful Skeptics

Psychedelic Reform

The psychedelics renaissance is here as a colorful trip down the line awaits.

July 6, 2020
Derya Ozdemir
Lucid News

MAPS Announces Findings from Phase 2 MDMA Clinical Trials for PTSD

Science & Research

MAPS published new evidence to support MDMA-assisted psychotherapy’s lasting benefits for PTSD.

July 6, 2020
Faye Sakallaridis
Psychedelics Today

The world needs healing, psychedelic drug advocates tell Ann Arbor council

Psychedelic Reform

Community members deserve access to medicines that have been used for thousands of years and shouldn’t fear prosecution for safe and effective treatments.

July 6, 2020
Ryan Stanton
Shutterstock

D.C. Would Vote To Decriminalize Psychedelics, Poll Shows

Psychedelic Reform

Voters would likely approve a measure to decriminalize psychedelics in the nation’s capital if organizers qualified it for November ballot.

July 6, 2020
Tom Angell
Marin Magazine

Psychedelics Outlook: A New Industry Emerges

Investor News

Heading into the second half of the year, industry experts and advocates are considering the current psychedelics outlook as the market continues to grow.

July 3, 2020
Bryan McGovern
Psymposia

Event: July 18-19 - Psychedelics 101 & 102 for Clinicians (Online)

Science & Research

This session for clinicians gives an overview of psychedelic drugs, their history, and current research with MDMA and Psilocybin-assisted therapy.

July 3, 2020
MAPS.org